D-0120 Safety and PK/PD Study in China

Clinical trial NCT03923868 · COMPLETED

Trial details

NCT number: NCT03923868
Sponsor: InventisBio Co., Ltd
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Hyperuricemia or Gout

Start date: 2019-04-18
Primary completion: 2021-12-31
Enrollment: 52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.